William Blair Has Optimistic Outlook of Allstate Q2 Earnings

The Allstate Co. (NYSE:ALL) – Equities researchers at William Blair upped their Q2 2025 EPS estimates for shares of Allstate in a note issued to investors on Thursday, May 1st. William Blair analyst A. Klauber now expects that the insurance provider will post earnings per share of $4.47 for the quarter, up from their prior forecast of $4.41. The consensus estimate for Allstate’s current full-year earnings is $18.74 per share. William Blair also issued estimates for Allstate’s Q4 2025 earnings at $6.96 EPS.

Other equities research analysts have also issued research reports about the stock. Argus raised shares of Allstate from a “hold” rating to a “buy” rating in a report on Monday, March 3rd. StockNews.com upgraded Allstate from a “hold” rating to a “buy” rating in a report on Thursday, May 1st. Evercore ISI increased their target price on shares of Allstate from $227.00 to $230.00 and gave the company an “outperform” rating in a research report on Thursday, May 1st. Wells Fargo & Company decreased their price target on shares of Allstate from $200.00 to $197.00 and set an “equal weight” rating on the stock in a research note on Tuesday. Finally, Keefe, Bruyette & Woods reduced their price target on Allstate from $240.00 to $228.00 and set an “outperform” rating on the stock in a report on Wednesday, April 9th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Allstate presently has a consensus rating of “Moderate Buy” and a consensus target price of $224.73.

Allstate Price Performance

NYSE:ALL opened at $202.42 on Monday. The stock has a market capitalization of $53.67 billion, a PE ratio of 11.91, a price-to-earnings-growth ratio of 1.01 and a beta of 0.32. Allstate has a 52 week low of $156.66 and a 52 week high of $212.91. The company has a quick ratio of 0.40, a current ratio of 0.36 and a debt-to-equity ratio of 0.42. The stock’s 50-day moving average price is $198.88 and its 200-day moving average price is $194.95.

Allstate (NYSE:ALL) last released its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $3.53 EPS for the quarter, missing the consensus estimate of $3.98 by ($0.45). The firm had revenue of $14.30 billion for the quarter, compared to analyst estimates of $16.41 billion. Allstate had a net margin of 7.28% and a return on equity of 28.20%. The firm’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $5.13 EPS.

Institutional Trading of Allstate

Several hedge funds have recently added to or reduced their stakes in ALL. Ameritas Advisory Services LLC boosted its position in shares of Allstate by 117.3% in the 4th quarter. Ameritas Advisory Services LLC now owns 4,896 shares of the insurance provider’s stock valued at $944,000 after purchasing an additional 2,643 shares during the period. Hennessy Advisors Inc. lifted its holdings in shares of Allstate by 6.9% during the fourth quarter. Hennessy Advisors Inc. now owns 58,600 shares of the insurance provider’s stock worth $11,297,000 after purchasing an additional 3,800 shares during the period. Los Angeles Capital Management LLC grew its position in Allstate by 10.5% in the 4th quarter. Los Angeles Capital Management LLC now owns 508,664 shares of the insurance provider’s stock valued at $98,065,000 after buying an additional 48,382 shares during the last quarter. Artemis Investment Management LLP increased its stake in Allstate by 33.3% in the 4th quarter. Artemis Investment Management LLP now owns 401,542 shares of the insurance provider’s stock valued at $77,413,000 after buying an additional 100,311 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Allstate by 56.0% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 186,792 shares of the insurance provider’s stock valued at $36,012,000 after buying an additional 67,032 shares during the period. Institutional investors and hedge funds own 76.47% of the company’s stock.

Insider Activity at Allstate

In other news, CFO Jesse E. Merten sold 40,102 shares of Allstate stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $186.53, for a total value of $7,480,226.06. Following the completion of the transaction, the chief financial officer now owns 18,115 shares in the company, valued at approximately $3,378,990.95. This trade represents a 68.88 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.80% of the stock is currently owned by company insiders.

Allstate Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, April 1st. Stockholders of record on Monday, March 10th were paid a $1.00 dividend. This is a boost from Allstate’s previous quarterly dividend of $0.92. This represents a $4.00 annualized dividend and a dividend yield of 1.98%. The ex-dividend date was Monday, March 10th. Allstate’s dividend payout ratio (DPR) is presently 27.32%.

Allstate declared that its board has initiated a stock repurchase program on Wednesday, February 26th that permits the company to buyback $1.50 billion in shares. This buyback authorization permits the insurance provider to purchase up to 3% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s leadership believes its stock is undervalued.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.